MEDWELL, LLC v. CIGNA CORPORATION

District Court, D. New Jersey·Decided December 28, 2020·No. 2:20-cv-10627·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

MEDWELL, LLC, Case No. 20–cv–10627–KM–ESK Plaintiff, v. OPINION AND ORDER CIGNA CORPORATION, et al., Defendants. KIEL, U.S.M.J. THIS MATTER is before the Court on the motion to seal (Motion to Seal) filed by defendants Cigna Corporation, Cigna Health and Life Insurance Company, Cigna Healthcare of New Jersey, Inc., and Connecticut General Life Insurance Company (collectively, defendants) (ECF No. 28), seeking an order sealing “Exhibits A and B” (ECF No. 23) to the Second Declaration of Steven L. Penaro, Esq. (ECF No. 22-2), which was submitted in support of defendants’ sur-reply (ECF No. 22) to plaintiff’s motion to remand (ECF No. 8). Plaintiff opposes the Motion to Seal. (ECF No. 34.) Defendants filed a reply brief in further support of the Motion to Seal. (ECF No. 36.) For the following reasons, the Motion to Seal is GRANTED. BACKGROUND Plaintiff filed the complaint in the Superior Court of New Jersey, Bergen County on July 3, 2020. (ECF No. 1-2.) Plaintiff is a healthcare provider that claims defendants stopped paying certain claims it submitted for services provided to defendants’ insureds. (Id. ¶¶ 9, 30, 31.) Plaintiff asserts: (i) breach of contract; (ii) breach of the implied covenant of good faith and fair dealing; (iii) quantum meruit; (iv) unjust enrichment; (v) promissory estoppel; (vi) equitable estoppel; (vii) tortious interference with current business relations; (viii) tortious interference with prospective economic advantage; and (ix) negligence. (ECF No. 1-2 pp. 10– 17.) Defendants removed this matter on August 17, 2020 pursuant to 28 U.S.C. §§ 1331, 1441, and 1446 because plaintiff’s claims “arise under and are preempted by the Employee Retirement Income Security Act of 1974 [(ERISA)] … thus supplying federal question jurisdiction.” (ECF No. 1 p. 1.) Plaintiff’s motion to remand followed. (ECF No. 8.) Defendants opposed, arguing, in part, that removal was proper under ERISA § 502 “because this Court has federal question jurisdiction over [plaintiff]’s unjust enrichment claim and supplemental jurisdiction over [plaintiff’s] remaining state law claims.” (ECF No. 13 p. 4.) In reply, plaintiff disputed whether defendants met their “obligation to first establish the existence of plans governed by” ERISA (id. p. 3), since defendants “failed to provide the actual copies of the plan documents [or] proof of the actual assignments for the Court’s review.” (ECF No. 14 pp. 12, 13.) On October 26, 2020, District Judge Kevin McNulty entered a procedural order (Procedural Order) stating, “[plaintiff] argues for the first time in its reply brief that [defendants] have failed to establish that there is no anti-assignment clause in [defendants’] plans with patients treated by [plaintiff] that would void any assignment.” (ECF No. 21 p. 1.) The demonstrable absence of an anti- assignment clause would support a finding of complete preemption under ERISA and thus establish the Court’s “federal question” subject matter jurisdiction. (Id. p. 2.) Judge McNulty directed defendants to file a sur-reply addressing the issue with “[a]ccompanying exhibits,” if necessary. (Id.) Defendants filed their sur-reply on November 2, 2020. (ECF No. 22.) The sur-reply included the Declaration of John P. DiManno, a Senior Advisor in

2 the Special Investigations Unit at “Cigna”1 (DiManno) (ECF No. 22-1), along with the Second Declaration of Steven L. Penaro, Esq. (ECF No. 22-2, with placeholders for “Exhibits A and B.” (ECF Nos. 22-3 and 22-4.) Exhibits A and B (Exhibits) were filed separately under seal. (ECF No. 23.) On November 11, 2020, plaintiff requested leave to file a sur-sur-reply (ECF No. 27), which the Court granted (ECF No. 29). On November 25, 2020, plaintiff filed a sur-sur-reply. (ECF No. 30.) Judge McNulty denied the motion to remand on December 4, 2020. (ECF Nos. 32, 33.) Judge McNulty found that “Cigna produced two ‘representative’ plans pursuant to which [plaintiff] submitted claims for reimbursement … Both plans affirmatively allow for assignments to a provider … So it would seem that Cigna has made the requisite showing.” (ECF No. 32 pp. 5, 6.) While the motion to remand was pending, the present Motion to Seal was filed on November 16, 2020. (ECF No. 28.) DISCUSSION I. THE PARTIES’ POSITIONS A. Defendants’ Position Defendants believe that the Exhibits “reflect important, commercially sensitive, highly confidential, and proprietary product details regarding the plan terms for plans that Cigna administers for its clients.” (ECF No. 28 ¶ 4.) According to defendants, the Exhibits also “reflect details regarding the operation of the plan and how benefits are paid … These details are the product of private contractual negotiations between Cigna and its clients,” and the plans “are the property of third parties, not Cigna, [so] Cigna is not at liberty to disclose the proprietary details of its clients’ benefit plans.” (Id. ¶¶ 5, 6.) They contend that

1 DiManno’s Declaration does not specify whether he is employed with Cigna Corporation, Cigna Health and Life Insurance Company, or Cigna Healthcare of New Jersey, Inc. (collectively, Cigna).

3 “[t]he disclosure of these details would place Cigna and its clients at a competitive disadvantage if one [of] their competitors obtained the proprietary information contained in the Exhibits.” (Id. ¶ 7.) Defendants also claim that “[a] less restrictive alternative to sealing the Exhibits is not available because Cigna must submit [the] Exhibits … in response to the Court’s Procedural Order … to establish that some of the benefit plans at issue do not contain anti-assignment provisions.” (Id. ¶ 8.) In support of the Motion to Seal, Defendants also rely on the Fourth Declaration of DiManno. (ECF No. 28-3.) DiManno declares that the information contained in the Exhibits “include[s] details regarding the operation of the benefit plan and how benefits are calculated and paid” and “are the product of private contractual negotiations between Cigna and its clients.” (Id. ¶ 8.) “This information, if made public, would cause harm to Cigna, as it would place Cigna [ ] at a competitive disadvantage if one of its competitors obtained the information in these documents.” (Id.) DiManno further declares that “Cigna considers these details proprietary and confidential and diligently protects against their disclosure to the public.” (Id. ¶ 9.) Defendants also provided a detailed Index with their Motion to Seal, satisfying Local Civil Rule 5.3(c)(3). The Index: (i) identifies the party requesting material to be sealed; (ii) describes the basis for sealing, i.e., the legitimate interest that warrants the relief sought; (iii) articulates clearly defined and serious injury that would result if the relief sought is not granted; and (iv) explains why a less restrictive alternative to the relief sought is not available. (ECF No. 28-4.) B. Plaintiff’s Position In opposition to the Motion to Seal, plaintiff points out that defendants have “routinely filed” documents relating to summary plan descriptions in other district courts without seeking to seal such documents. (ECF No. 34 p. 2.) Plaintiff also questions whether defendants’ attempt to confer with plaintiff on the

4 matter of sealing the subject Exhibits, pursuant to Local Civil Rule 5.3(c)(2)(i), was “meaningful.” (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

MEDWELL, LLC v. CIGNA CORPORATION, (D.N.J. 2020).

MEDWELL, LLC v. CIGNA CORPORATION (MEDWELL, LLC v. CIGNA CORPORATION) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related